A carregar...

Novel Therapeutic Agents Against Cancer Stem Cells of Chronic Myeloid Leukemia

Chronic myeloid leukemia (CML) is induced by the BCR-ABL oncogene, a product of Philadelphia (Ph) chromosome. The BCR-ABL kinase inhibitor imatinib is a standard treatment for Ph(+) leukemia, and has been shown to induce a complete hematologic and cytogenetic response in most chronic phrase CML pati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chen, Yaoyu, Peng, Cong, Sullivan, Con, Li, Dongguang, Li, Shaoguang
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3136127/
https://ncbi.nlm.nih.gov/pubmed/20184539
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!